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This paper aims to evaluate the eﬃcacy of intravitreal ultrasound (US) irradiation for green ﬂuorescent protein (GFP) plasmid
transfer into the rabbit retina using a miniature US transducer. Intravitreal US irradiation was performed by a slight modiﬁcation
of the transconjunctival sutureless vitrectomy system utilizing a small probe. After vitrectomy, the US probe was inserted through
a scleral incision. A mixture of GFP plasmid (50µL) and bubble liposomes (BLs; 50µL) was injected into the vitreous cavity, and
US was generated to the retina using a SonoPore 4000. The control group was not exposed to US. After 72h, the gene-transfer
eﬃciency was quantiﬁed by counting the number of GFP-positive cells. The retinas that received plasmid, BL, and US showed
a signiﬁcant increase in the number (average ± SEM) of GFP-positive cells (32 ± 4.9; n = 7; P<0.01). No GFP-positive cells
were observed in the control eyes (n = 7). Intravitreal retinal US irradiation can transfer the GFP plasmid into the retina without
causing any apparent damage. This procedure could be used to transfer genes and drugs directly to the retina and therefore has
potential therapeutic value.
1.Introduction
Ultrasound (US) increases the permeability of the plasma
membrane and reduces the thickness of the unstirred layer
at the cell surface, thereby facilitating the entry of DNA into
cells. Furthermore, a combination of low-intensity US and
m i c r o b u b b l e( M B )e c h o c o n t r a s ta g e n t sa l l o w sd i r e c tD N A
transfer into the cytosol through small pores in the cells
caused by cavitation eﬀects, and dramatically enhances gene
transfection both in vitro and in vivo [1–4]. Previously, our
group reported that combination of US and MB increases
the induction eﬃciency of plasmid DNA in the surface of
oculartissuessuchascornea,conjunctiva,andeyelid[1,5,6].
The retina deeper part of ocular tissue was more hard to
deliver DNA because of diﬃculties of US exposure, we also
demonstrated a possibility of transcorneal US irradiation
with MB transfer of DNA plasmids into the retina (Sonoda
S, et al. IOVS 2006;47:ARVO E-Abstract 828). However, the
eﬃciency of DNA plasmid induction was not so high and
the applications of US irradiation to retina were limited to
external irradiation form the cornea due to US probe size.
Furthermore the lack of targeting ability of this transcorneal
method meant that unpredictable eﬀects might occur in
other tissues, such as the lens, iris, and ciliary body. Selective
retinal transfection would thus be advantageous to improve
induction eﬃciency and avoid unexpected US exposure.
A clinical application of a new therapeutic US method
for treating thrombosis has been developed [7, 8]. This
method employs a miniature US transducer at the tip of a
MicroLysUS infusion catheter (EKOS Corp., Bothell, USA),
which approaches the target site via arterial vessels, and has
been shown to improve clinical outcomes [7–9]. We have
explored the use of this concept to apply US at shorter
distances with a smaller probe, which should allow us to
irradiate US selectively and to minimise the damage to the
other ocular tissues. Our group developed a tiny US probe
as small as a 19-gauge needle which can insert to vitreous
cavity and exposure US selectively to retina. The aim of2 Journal of Ophthalmology
the present study was to evaluate the plasmid DNA deliver
eﬃcacy of intravitreal US irradiation using a miniature US
transducer.Thismanuscriptistheﬁrstattemptofintravitreal
US irradiation to retina.
2. Methods
All of the animals were handled humanely in strict accor-
dance with the Association for Research in Vision and
Ophthalmology (ARVO) Statement for the Use of Animals
in Ophthalmic and Vision Research, and with the approval
of the ethics board of Kagoshima University, Japan. Male
New Zealand albino rabbits (age = 14 weeks; body weight =
3kg; KBT Oriental Co. Ltd., Saga, Japan) were anesthetised
with an intramuscular injection of ketamine hydrochloride
(14mg/kg) and then xylazine hydrochloride (14mg/kg).
The procedures speciﬁcally followed the transconjunctival
sutureless vitrectomy system (TSV) [10, 11]. Using a trocar
cannula (25G trocar cannula system, Alcon, Fort Worth,
Texas, USA), three incisions were made in the inferotem-
poral, superotemporal, and superonasal quadrants, and
an infusion cannula was inserted into the inferotemporal
incision (Figure 1(a)). Vitrectomy was performed with an
accurus800CSwitha25-gaugeTSV(Alcon).Thecentraland
preretinal vitreous was excised to allow suﬃcient room for
agentinjections. Then, thesuperonasalincision wasenlarged
using a 19-gauge needle (Terumo, Tokyo, Japan) to allow the
U Sp r o b et ob ei n s e r t e d( F i g u r e s1(b) and 1(f)).
A bubble liposome (BL) is a type of MB that has been
d e v e l o p e db yo u rg r o u pt oa l l o wm o r ee ﬃcient gene transfer
into a target site than conventional MBs [5, 6, 12–14].
The BLs were prepared following the methods described in
our previous report [15]. Green ﬂuorescent protein (GFP)
coding plasmid (pEGFP-N2, Clontech, Mountain View, CA,
USA; 50µL )w a sm i x e dw i t hB L s( 5 0µL), and then injected
at a slow speed (for 30s) into the generated preretinal space
through the cannula, using a syringe with a 27-gauge blunt
needle (Nipro, Osaka, Japan). During the injection, the
US probe was positioned 1-2mm from the central part of
the optic disc of the retina, and US (frequency = 3MHz;
duty=6%; intensity = 0.15W/cm2;t i m e= 60s) was applied
to the retina using a SonoPore 4000 (NEPA GENE, Chiba,
Japan)(Figures1(c)and1(d)).Thecontrolgroupwastreated
using identical procedures but without US exposure (BL +
plasmid). Immediately after the US exposure, we conﬁrmed
the rupture of the BLs, which indicated the occurrence of
cavitation [1, 2, 16]. The sclera incision port, which was used
for the US probe, was then sutured with 10-0 nylon (Alcon),
and the other microcannulas that did not require sutures
were removed (Figure 1(e)). Finally, antibiotic ointment was
applied to the conjunctival sac (whole procedure movie;
see supplementary ﬁle in supplementary material available
online at doi:10.1155/2012/412752). We also conﬁrmed the
condition used plasmid alone following US irradiation (US
+ plasmid).
Theeyeswereenucleated72haftertreatment,andimme-
diately frozen in liquid nitrogen-cooled isopentane. Serial
sections were sliced with a cryostat adjacent area of optic
disc where US were exposed. The GFP was observed by laser
Table 1: Quantiﬁcation of gene-transfer eﬃciency by counting the







(BL+ plasmid) No positive cell
US +BL+plasmid 32.0 ± 4.9
P<0.01 (versus
control and US +
plasmid)
US +plasmid 4.2 ± 2.7 P<0.01 (versus
control)
confocal microscopy (FV-1000; Olympus, Tokyo, Japan).
The gene-transfer eﬃciency was quantiﬁed by measuring
the intensity of GFP-positive cells randomly selected four
sections form each rabbit and calculated average number by
three masked observers. Seven rabbit eye were treated for
each condition.
3. Results
No GFP-positive cells were observed in the control eyes (n =
7; Figure 2(a)); however, the retinas that received plasmid
and US concomitantly with or without BL showed GFP-
positive cells (Figure 2(b)). Importantly, the GFP-positive
cells were limited to the area exposed to US, and were
observed mainly in the outer nuclear layer. The average
number of GFP-positive cells in BL + plasmid + US group
was 32.0 ± 4.9( m e a n± SEM, n = 7) per visual ﬁeld and
4.2 ± 2.7( m e a n± SEM, n = 7) in plasmid + US group with
×200 magniﬁcation (Table 1). Induction eﬃciency of BL +
plasmid+USwasastatisticallysigniﬁcantincrease(P<0.01,
Mann-Whitney U test) compared with both control and US
+ plasmid group.
Slit-lamp biomicroscopy examinations were performed
1 day and 3 days after treatment, and revealed no obvious
tissue damage (i.e., an intact bulb shape, no cells in the ante-
rior chamber, and no preretinal haemorrhage). Histological
examinations by hematoxylin and eosin (H&E) staining
showed no critical retinal damage in any of the treatment
groups (Figure 2(c)).
4. Discussion
In this study, direct intravitreal retinal US irradiation
transferred the GFP plasmid to the rabbit retina without any
apparent tissue damage. Furthermore, combining the GFP
plasmid with BLs greatly enhanced the gene delivery. To our
knowledge, this is the ﬁrst report to attempt intravitreal US
irradiation with a 25-gauge TSV system. Diameter of US
transducerscommonlyusedforgenedeliverywere3mmand
more, therefore only transcorneal US irradiation could be
available on occasions when US was exposed to the retina,
deeper portion of ocular tissue. Our preliminary study using
transcorneal US exposure to retina showed (Sonoda S, et al.







Figure 1: (a) Vitrectomy was performed with a 25-gauge vitrectomy system with rabbit eye. (b) Enlarge the superonasal incision with 19G
needle (arrow) for the insertion of the US probe. (c) The eye ball had preserved intact after insertion of the US probe. (d) Bubble liposome
was injected through the superotemporal port (arrowhead) and US irradiation (asterisk) was performed simultaneously. (e) The eye ball
was kept intact after whole procedures. (f) The US probe size is as small as a 19G needle.
(a) (b) (c)
Figure 2: (a) No-GFP positive cells were observed in the control (plasmid + BL without US), (b) In the group treated with plasmid + BL +
US, GFP-positive cells were observed exclusively in the area where US was exposed, and located in the outer nuclear layer. (c) H&E staining
showed no obvious tissue damage. Bar equals 100µm.
plasmid was employed instead of GFP, we could not compare
accurately,scatteredpositivestainingcells(11.3±3.2,mean±
SEM, n = 6) were only observed in superﬁcial layer of retina.
In this study with intravitreal US irradiation, the average
number of positive staining cells was obviously larger than
transcorneal US exposure.
Our group had achieved to minimize the diameter of
US probe which is enough small to insert vitreous cavity.
On the contrary, the US probe, was not customized for the
only purpose for intravitreal US irradiation, still remaining
problems are such as ring sonography transducer that
generate a 360◦ circumferential pulse and US intensity was
not specially tuned for retina. Even this type of US probe
could transfer GFP plasmid into retina. In other word,
development of a US probe specialised for ocular tissue,
for example, with optimal US intensity and unidirectional
US irradiation towards the retina, might increase the gene-
transfer eﬃciency. Furthermore, reducing the size of the
US probe could avoid the need for additive sclera incision,
reduce the procedure time, and potentiate the no-suture4 Journal of Ophthalmology
minimal surgery of the 25 G TSV system. Taken together,
Intravitreal US irradiation may have potential therapeutic
value.
GFP-positive cells were observed exclusively in the area
that was exposed to US. This indicates that intravitreal US
exposureismoreselectivefortheretinathanthetranscorneal
method, thereby avoiding gene delivery to unexpected areas
and minimizing the damage to the surrounding tissues. It
is not clear why GFP-positive cells were observed mainly in
the outer nuclear layer, although some possible explanations
are as follows. In the present procedure, the US intensity
was focused on the outer layer of the retina, which might
have increased the gene transfer speciﬁcally to that layer.
Another possibility is that retinal pigment epithelial (RPE)
cells that are highly polarised with tight junctions produce
a tight blood-retinal barrier [17], and the US intensity used
i nt h i ss t u d ym i g h th a v en o tb e e ns u ﬃcient to break the RPE
barrier.Furtherexperimentswillbeneededtoelucidatethese
mechanisms.
The present procedure used the BL, which is a type of
MB devised by our group that is based on liposome technol-
ogy, and comprises a polyethylene-glycol-modiﬁed liposome
(PEG-liposome) containing perﬂuoropropane (C3F8)g a s[ 6,
12, 15]. In the case of intravitreal US, only the combination
of BL plus US exposure enhanced the gene-transfer eﬃ-
ciency. As described in previous reports [1, 2, 6], trapped gas
inside the BL is cavitated by US, enhanced to form microjet
ﬂow, and allows easy gene entry into the cell [13, 15]. The
BL has several advantages compared with the conventional
and well-studied MB, the Optison (GE Healthcare, Little
Chalfont, UK). The BL can be modiﬁed to incorporate
additional components, such as targeting functions, as it was
developed based on liposome technology, besides BL was
incompatible with DNA plasmid and drugs easily [18, 19].
Furthermore, components of the BL are already in use in
clinical applications, and US has also been used clinically for
alongtime[15,20].Basedonthesefacts,thepresentmethod
is likely to be safe for human treatment.
Again, the major advantage of this method was selective
US irradiation in vitreous cavity with minimal side eﬀect.
This concept would be applicable to treat various retinal
diseases. Retinal detachment (RD) is one of the good can-
didate diseases for this method, because the present method
can be easily applied during vitrectomy and the gene transfer
ofneuroprotectiveoranti-apoptoticfactormightpreventthe
further deterioration of vision [21, 22]. Now we established a
rabbit RD model to evaluate the possibility of our method. If
this concept would be proven by this model, the application
would be widely expanded to such disease as retinitis
pigmentosa and glaucoma.
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